AL
Therapeutic Areas
EpiBiologics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| c-MET Degrading Bispecific Antibody | Oncology (likely various solid tumors) | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| c-MET Degrading Bispecific Antibody | Oncology (likely various solid tumors) | Preclinical |